Clinical Trials Sponsored by Vesale Pharmaceutica

Total 20298 results

Société des Produits Nestlé (SPN)
Nestlé Health Science

Recruiting

To Evaluate Clinical Efficacy and Safety of Diabetes-Specific Formula (Nutren Diabetes)

Diabetes Mellitus

China
Ecole Polytechnique Fédérale de Lausanne
Nestlé Health Science

Recruiting

Effect of Circadian Rhythm on Brain NAD Measured by Phosphorus Magnetic Resonance Spectroscopy at 7 Tesla (ChronoBrain)

Circadian Rhythm

Switzerland
Gruppo Italiano Carcinoma Renale

Unknown

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

Italy
Elena Pita Calandre
Ferring Pharmaceuticals; Actial Farmaceutica S.r.l.

Completed

Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia

Fibromyalgia | Gastrointestinal Disease

Spain
Vejle Hospital
The University of Hong Kong

Completed

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma (ACVDL)

Multiple Myeloma

Denmark
ISA Pharmaceuticals
Regeneron Pharmaceuticals

Active, not recruiting

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Squamous Cell Carcinoma of the Oropharynx | HPV16 Positive

Netherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 4 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist

Hepatic Impairment

United States
Portola Pharmaceuticals

Withdrawn

BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

Venous Thromboses

United States
Jazz Pharmaceuticals
GW Pharmaceuticals

Completed

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Seizures | Tuberous Sclerosis Complex

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
Foresee Pharmaceuticals Co., Ltd.
QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Puberty; Precocious, Central

United States, China, Taiwan, Puerto Rico
Henan Cancer Hospital
Qilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.

Not yet recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Healthy Volunteers

United States
Portola Pharmaceuticals

Withdrawn

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

AITL | Peripheral T-Cell Lymphoma (PTCL NOS) | Nodal Lymphomas of T Follicular Helper (TFH) | Follicular T-cell Lymphoma (FTCL) | ALCL | HSTCL | EATL I,II | MEITL, EATL Type II | Nasal Lymphoma
Portola Pharmaceuticals

Completed

A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban

Bleeding

United States
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers

Healthy

Belgium
Ferring Pharmaceuticals
Xanodyne Pharmaceuticals

Completed

A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Menorrhagia

United States
Italian Academy of Rhinology
Accademia Italiana di Citologia Nasale

Recruiting

Rhinosinusitis Italian Network: the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis (RINET)

Chronic Rhinosinusitis

Italy
Beijing Institute of Heart, Lung and Blood Vessel...

Not yet recruiting

China Diabetes Cardiovascular Initiative (CDCV)

Diabetes Mellitus | Acute Coronary Syndrome
Beijing Institute of Heart, Lung and Blood Vessel...

Recruiting

A Registry Study on Serumal Biomarkers About Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting. (ASBA-CABG)

Cardiac Surgery

China
Beijing Institute of Heart, Lung and Blood Vessel...

Active, not recruiting

A Registry Study on Genetics and Biomarkers of Acute Coronary Syndrome (ARSGB-ACS)

Coronary Artery Disease | Acute Coronary Syndrome | Acute Myocardial Infarction | Unstable Angina

China
Beijing Institute of Heart, Lung and Blood Vessel...

Unknown

Chinese Multi-provincial Cohort Study-Beijing Project (CMCS-Beijing)

Cardiovascular Diseases | Sleep | Cardiovascular Risk Factor | Aging Problems | Smell Disorder

China
Beijing Institute of Heart, Lung and Blood Vessel...

Unknown

Prognostic Value of Plasma Biomarkers Among Patients With Hypertension (BIOMS-HTN)

Hypertension

China
Universiti Putra Malaysia
Joslin Diabetes Center; Nestlé Health Science

Unknown

Malaysia Diabetes Ramadan Nutrition Plan (My Dia-RNP®): A Feasibility Study (MyDia-RNP)

Type 2 Diabetes Mellitus

Malaysia
University College of Southeast Norway
Vestre Viken Hospital Trust

Unknown

Pain in Chronic Leg- and Foot Ulcers

Pain | Leg Ulcer

Norway
Female Pelvic Medicine & Urogynecology Institute...
Ethicon, Inc.

Completed

ThermaChoice III Under Local Sedation in the Office Setting

Heavy Uterine Bleeding

United States
Vejle Hospital
The Ottawa Hospital Research Institute

Recruiting

Impact of a Patient Decision Aid Intervention (IMPACTT)

Cancer, Breast | Cancer Colorectal

Denmark
Chugai Pharmaceutical

Not yet recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS) | Immune Thrombocytopenia (ITP) | Dermatomyositis (DM) | Bullous Pemphigoid (BP) | Behçet's Syndrome (BS) | Immune-mediated Necrotizing Myopathy (IMNM)

United States, Japan
BioMarin Pharmaceutical

Recruiting

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

Phenylketonuria (PKU)

United States
Chugai Pharmaceutical

Recruiting

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Solid Tumor

United States, Japan
Xintian Pharmaceutical

Recruiting

The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia (NQTIPS)

Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

China
Chugai Pharmaceutical

Not yet recruiting

Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

China
Chugai Pharmaceutical

Recruiting

A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

Taiwan, Japan
Chugai Pharmaceutical

Recruiting

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Locally Advanced or Metastatic Solid Tumors

United States, Japan
JW Pharmaceutical

Recruiting

The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors

Hemophilia A With Inhibitor | Hemophilia A Without Inhibitor

Korea, Republic of
Chugai Pharmaceutical

Recruiting

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Locally Advanced or Metastatic Solid Tumors

United States, Japan
BioMarin Pharmaceutical

Enrolling by invitation

Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia

Hypochondroplasia

United States, Australia
BioMarin Pharmaceutical

Enrolling by invitation

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401) (GENEr8-LTE)

Hemophilia A

United Kingdom, United States
JW Pharmaceutical

Completed

To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers

Healthy

Korea, Republic of
JW Pharmaceutical

Completed

To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

Healthy

Korea, Republic of
JW Pharmaceutical

Completed

To Evaluate the Safety and PK Characteristics in Healthy Volunteers

Healthy

Korea, Republic of
Xintian Pharmaceutical

Completed

Clinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic Lithotripsy (3)

Ureteral Calculi
BioMarin Pharmaceutical

Completed

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg (GENEr8-2)

Hemophilia A

United States
Xintian Pharmaceutical

Completed

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis

China
BioMarin Pharmaceutical

Completed

Kuvan®'s Effect on the Cognition of Children With Phenylketonuria (KOGNITO)

Phenylketonuria

Italy, Spain, United Kingdom, Germany
Zeria Pharmaceutical

Completed

A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia

Hyperkalemia

Japan
Chugai Pharmaceutical

Completed

A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer

Healthy Volunteers

Netherlands

Clinical Trials Sponsored by Vesale Pharmaceutica

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations